Latest Evista news
Raloxifene Does Not Appear to Boost Cognition in Alzheimer’s
posted November 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Raloxifene doesn't benefit cognition in women who have mild to moderate dementia due to Alzheimer's disease, according to a small study published online Nov. 4 in Neurology.
Editor's Recommendations
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Exercise Link to Dementia Varies by Physical Activity Domain 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy Related Articles
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Monthly Specialist Briefings
Stay Connected
